
Sign up to save your podcasts
Or


In this episode recorded on December 13th, IDSA President-Elect Carlos del Rio, MD, FIDSA and IDSA Public Health Committee Chair Julie Vaishampayan, MD, FIDSA share what the medical community knows thus far about the Omicron variant, including its impact on current COVID-19 treatments and why testing plays a key role.
By Infectious Diseases Society of America (IDSA)3.9
129129 ratings
In this episode recorded on December 13th, IDSA President-Elect Carlos del Rio, MD, FIDSA and IDSA Public Health Committee Chair Julie Vaishampayan, MD, FIDSA share what the medical community knows thus far about the Omicron variant, including its impact on current COVID-19 treatments and why testing plays a key role.

32,246 Listeners

43,687 Listeners

321 Listeners

2,053 Listeners

701 Listeners

504 Listeners

3,374 Listeners

113,121 Listeners

518 Listeners

367 Listeners

170 Listeners

14,324 Listeners

188 Listeners

29 Listeners

91 Listeners